| Richard Hansen |
Richard
A
Hansen
PhD
Assistant Professor |
Office |
Phone
Fax
Email |
Document Actions
Dr. Hansen is a pharmacist that specializes in pharmaceutical outcomes research. He has expertise in secondary database analysis, systematic review, and pharmaceutical policy analysis. In general, his research focuses on health outcomes as a function of clinical intervention. He is especially interested in understanding real-world parameters (e.g., access, adherence, cost, patient preferences, and promotion) that influence treatment decisions and subsequent health outcomes. His previous work in this area has included secondary analysis of private and public data, focusing on factors such as insurance design (e.g., cost-sharing, prior authorization, spending limits) and pharmaceutical promotion. Through this work, he has demonstrated the impact of these variables on medication prescribing, utilization, and health outcomes.
In addition, Dr. Hansen is a member of the UNC-RTI Evidence-based Practice Center. He has conducted systematic reviews and meta-analyses for the Drug Effectiveness Review Project – a consortium of Medicaid payers interested in making evidence-based coverage decisions. This work focuses on comparing the effectiveness and tolerability of multiple agents within the same therapeutic area to help guide decision-making. He has authored comparative drug class reviews in the areas of mental health, dementia, asthma, and chronic obstructive pulmonary disease, arthritis, and Crohn’s disease. A similar review of depression treatments currently is funded by the Agency for Healthcare Research and Quality (AHRQ) to help guide decision-making under the Medicare Modernization Act (MMA).
Furthermore, Dr. Hansen is interested in pharmaceutical policy and has expertise in policy analysis. Incorporating his evidence-based research, he has conducted studies exploring the effects of policy changes on spending and utilization. In this regard, he has skills in time series analysis and quasi-experimental design. He is especially interested in exploring the effects of Medicaid and Medicare payment decisions on population outcomes.